:::

詳目顯示

回上一頁
題名:抗癌納米藥物中藥用輔料對轉運蛋白的抑制作用
書刊名:澳門科技大學學報
作者:李良易濤林偉基
作者(外文):Li, LiangYi, TaoLam, Christopher WaiKei
出版日期:2012
卷期:6:1
頁次:頁8-15
主題關鍵詞:抗癌納米藥物轉運蛋白藥用輔料Anticancer nanodrugsTransportersPharmaceutical excipients
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:53
期刊論文
1.Yi, T.、Wan, J. L.、Xu, H. B.、Yang, X. L.(2008)。A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs。Eur. J. Pharm. Biopharm,70,439-444。  new window
2.Yi, T.、Wan, J. L.、Xu, H. B.、Yang, X. L.(2008)。Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose。Eur. J. Pharm. Sci,34,274-280。  new window
3.Ferrari, M.(2005)。Cancer nanotechnology: opportunities and challenges。Nature Reviews Cancer,5,161-171。  new window
4.Ambudkar, S. V.、Kimchi-Sarfaty, C.、Sauna, Z. E.、Gottesman, M. M.(2003)。Pglycoprotein: from genomics to mechanism。Oncogene,22,7468-7485。  new window
5.Senior, A. E.、al-Shawi, M. K.、Urbatsch, I. L.(1995)。The catalytic cycle of P-glycroprotein。FEBS Lett,377,285-289。  new window
6.Higgins, C. F.(1991)。Molecular basis of multidrug resistance mediated by Pglycoprotein。Curr. Opin. Biotechnol,2,278-281。  new window
7.en, C. J.、Chin, J. E.、Ueda, K.、Pastan, O.、Gottesman, M. M.、Roninson, I. B.(1986)。Internal duplication and homology with bacterial transport proteins in the mdrl (P-glycoprotein) gene from multi-drug resistance human cells。Cell,47,381-389。  new window
8.Loth, P. T.、Lou, H. X.、Zhao, Y.、Chin, Y. M.、Vathsala, A.(2008)。Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients。Transplant. Proc,40,1690-1695。  new window
9.Akiyama, S. I.、Cornwell, M. M.、Kuwano, M.、Pastan, I.、Gottesman, M. M.(1988)。Most drugs that reverse multidrug resistance also inhibit photoaffinity labelling of P-glycoprotein by vinblastine analog。Mol. Pharmacol,33,144-147。  new window
10.Mouly, S.、Paine, M. F.(2003)。P-glycoprotein increases from proximal to distal regions of human small intestines。Pharm. Res,20,1595-1599。  new window
11.Gottesman, M. M.、Pastan, I.(1993)。Biochemistry of multidrug resistance mediated by the multidrug transporter。Annu. Rev. Biochem,62,385-427。  new window
12.Wang, Q.、Bhardwaj, R. K.、Herrera-Ruiz, D.、Hanna, N. N.、Gudmundsson, O. S.、Buranachokpaisan, T.、Hidalgo, I. J.、Knipp, G. T.(2004)。Expression of multiple drug resistance conferring proteins in normal Chinese and Caucasian small and large intestinal tissue samples。Mol. Pharm,1,447-454。  new window
13.Peng, K. C.、Cluzeaud, F.、Bens, M.、Van Huyen, J. P.、Wioland, M. A.、Lacave, R.、Vandewalle, A.(1999)。Tissue and cell distribution of the multidrug resistanceassociated protein (MRP) in mouse intestine and kidne。J. Histochem. Cytochem,47,757-768。  new window
14.Cole, S. P. C.、Bhardwaj, G.、Gerlach, J. H.、Mackie, J. E.、Grant, C. E.、Almquist, K. C.、Deeley, R. G.(1992)。Over expression of a transporter gene in a multidrug-resistant human lung cancer cell line。Science,258,1650-1654。  new window
15.Zimmermann, C.、Gutmann, H.、Hruz, P.、Gutzwiller, J. P.、Beglinger, C.、Drewe, J.(2005)。Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract。Drug Metab. Dispos,33,219-224。  new window
16.Doyle, L. A.、Yang, W.、Abruzzo, L. V.、Krogmann, T.、Gao, Y.、Rishi, A. K.、Ross, D. D.(1999)。A multidrug resistance transporter from human MCF7 breast cancer cells。Proc. Natl. Acad. Sci. U.S.A.,95,15665-15670。  new window
17.Scheffer, G. L.、Maliepart, M.、Pijnenborg, A. C.、van Gastelen, M. A.、de Jong, M. C.、Schroeijers, A. B.、Scheper, R. J.(2000)。Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone and topotecan-resistant cell lines。Cancer Res,60,2589-2593。  new window
18.Gutmann, H.、Hruz, P.、Zimmermann, C.、Beglinger, C.、Drewe, J.(2005)。Distribution of breast cancer resitance protein (BCRP/ABCG2) mRNA expression along the human GI tract。Biochem. Pharmacol,70,695-699。  new window
19.Eisenblatter, T.、Galla, H. J.(2005)。A new multidrug resistance protein at the blood-brain barrier。Biochem. Biophys. Res. Commun,293,1273-1278。  new window
20.Martin, G. P.、Mariott, C.、Kellaway, I. W.(1978)。Direct effect of bile salts and phospholipids on the physical properties of mucus。Gut,19,1103-1107。  new window
21.Tomita, M.、Hyashi, M.、Horie, T.、Ishizawa, T.、Awazu, S.(1988)。Enhancement of colonic drug absorption by the transcellular permeation route。Pharm. Res,5,786-789。  new window
22.Ferte, J.(2000)。Analysis of tangled relationship between P-glycprotein mediated multidrug resistance and the lipid phase of the cell membrane。Eur. J. Biochem,267,277-294。  new window
23.Tayrouz, Y.、Ding, R.、Burhenne, J.、Riedel, K.-D.、Weiss, J.、Hoppe-Tichy, T.、Mikus, G.(2003)。Pharmacokinetic and pharmaceutic interaction between digoxin and cremophor RH40。Pharmacol. Ther,73,397-405。  new window
24.Wandel, C.、Kim, R. B.、Stein, C. M.(2003)。“Inactive” excipients such as Cremophor can affect in vivo drug disposition。Clin. Pharmacol. Ther,73,394-396。  new window
25.Rege, B. D.、Kao, J. P. Y.、Polli, J. E.(2002)。Effects of non-ionic surfactants on membrane transporters in Caco-2 cell monolayers。Eur. J. Pharm. Sci,16,237-246。  new window
26.Yamagata, T.、Kusuhara, H.、Morishita, M.、Takayama, K.、Benameur, H.、Sugiyama, Y.(2007)。Effect of excipients on breast cancer resistance protein substrate uptake activity。J. Control. Release,124,1-5。  new window
27.Yamagata, T.、Kusuhara, H.、Morishita, M.、Takayama, K.、Benameur, H.、Sugiyama, Y.(2007)。Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients。Drug Metab. Dispos,35,1142-1148。  new window
28.Hugger, E. D.、Novak, B. L.、Burton, P. S.、Audus, K. L.、Borchardt, R. T.(2002)。A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro。J. Pharm. Sci,91,277-294。  new window
29.Shen, Q.、Lin, Y.、Handa, T.、Doi, M.、Sugie, M.、Wakayama, K.、Yamamoto, A.(2006)。Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies。Int. J. Pharm,313,49-56。  new window
30.Hugger, E. D.、Audus, K. L.、Borchardt, R. T.(2002)。Effects of poly (ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers。J. Pharm. Sci,91,1980-1990。  new window
31.Krylova, O. O.、Pohl, P.(2004)。Ionophoric activity of Pluronic block copolymers。Biochem,43,3696-3703。  new window
32.Baggetto, L. G.、Testa-Parussini, R.(1990)。Role of acetoin on the regulation of intermediate metabolism of Ehrlich ascites tumor mitochondria: its contribution to membrane cholesterol enrichment modifying passive proton permeability。Arch. Biochem. Biophys,283,241-248。  new window
33.Cerf, E.、Gasper, R.、Rychnovsky, S.、Chang, X. B.、Buyse. F.、Ruysschaert, J. -M.(2007)。Multidrug resistance protein 1 is not associated to detergent-resistant membranes. Biochem。Biochem. Biophys. Res. Commun,355,1025-1030。  new window
34.Shun, Y.、Liu, H.(2007)。Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in vinblastine-resistant human lymphoblastic leukaemia cell line。Biochem. Cell Biol,85,638-646。  new window
35.Cui, S. X.、Nie, S. F.、Li, L.、Wang, C. G.、Pan, W. S.、Sun, J. P.(2009)。Preparation and evaluation of self-microemulsifying drug delivery system containing Vinpocetine。Drug. Dev. Ind. Pharm,35,603-611。  new window
36.Oh, D. H.、Kang, J. H.、Kim, D. W.、Lee, B. J.、Kim, J. O.、Yong, C. S.、Choi, H. G.(2011)。Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier。Int. J. Pharm,420,412-418。  new window
37.Huang, D.、Yi, T.、Liu, Y.、Xiao, L.、He, J. K.(2011)。Influence of hydroxypropylmethylcellulose on Digestion of Self-Microemulsifying Drug Delivery System in Gastro-Intestinal Tract in Vitro。Chin. Pharma. J.,7,527-531。  new window
圖書
1.楊祥良、曾繁典、徐輝碧(2007)。納米藥物。北京:清華大學出版社。  延伸查詢new window
2.Balimane, P. V.、Chong, S.(2008)。Biopharmaceutics applications in drug development。Evaluation of Permeability and P-glycoprotein Interactions: Industry Outlook。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE